Pykosz Michael T's Form 4/A amendment
AmendedOak Street Health, Inc. (OSH) · filed Mar 9, 2022
- Accession no.
- 0001209191-22-017613
- Filed
- Mar 9, 2022
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 5, 2022
This filing lists no transactions. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $829.8K.
This amendment restates part of 0001209191-22-001769 (filed Jan 5, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pykosz Michael TCIK 0001793308 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-22-001769 (filed Jan 5, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | Common Stock, $0.001 par value | AGrant or awardDisposed | −417 | $28.17F3 | −$11,746.89 | 7,371,584 | Direct | |
| Jan 4, 2022 | Common Stock, $0.001 par value | SSaleDisposed | −16,730 | $32.87F5 | −$549,915.1 | 7,354,854 | Direct | |
| Jan 4, 2022 | Common Stock, $0.001 par value | SSaleDisposed | −6,870 | $33.73F6 | −$231,725.1 | 7,347,984 | Direct | |
| Jan 4, 2022 | Common Stock, $0.001 par value | SSaleDisposed | −1,400 | $34.39F7 | −$48,146 | 7,346,584 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F3
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on December 31, 2021.
Referenced by the price of 1 transaction in Table I.
- F5
Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $32.33 and maximum price was $33.32.
Referenced by the price of 1 transaction in Table I.
- F6
Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $33.33 and maximum price was $34.31.
Referenced by the price of 1 transaction in Table I.
- F7
Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $34.38 and maximum price was $34.44.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The original Form 4 filed on January 5, 2022 is being amended by this Form 4 amendment solely to correct administrative errors that resulted in the total number of shares of common stock reflected in column 5 to be overstated by 2,109 shares of common stock. The amount reported in column 5 herein reports the total number of shares of common stock held by the Reporting Person as of January 4, 2022.